Posted by Michael Wonder on 26 Sep 2023
Cara Therapeutics announces approval of Korsuva IV injection syringe in Japan for the treatment of pruritus in haemodialysis patients
25 September 2023 - Approval triggers $1.5 million milestone payment to Cara.
Cara Therapeutics today announced that its licensing partner Maruishi Pharmaceutical received manufacturing and marketing approval from Japan’s Ministry of Health, Labour and Welfare for Korsuva IV injection syringe for the treatment of pruritus in haemodialysis patients.
